Sue Down

1.3k total citations
25 papers, 404 citations indexed

About

Sue Down is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Sue Down has authored 25 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 9 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Sue Down's work include Breast Cancer Treatment Studies (14 papers), Breast Implant and Reconstruction (8 papers) and Breast Lesions and Carcinomas (7 papers). Sue Down is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Implant and Reconstruction (8 papers) and Breast Lesions and Carcinomas (7 papers). Sue Down collaborates with scholars based in United Kingdom, Australia and Portugal. Sue Down's co-authors include Maged Hussien, Giles W. Story, Clare Wilson, Adrian Harris, Shiraz Badurdeen, James Harvey, Anthony Maxwell, N.J. Bundred, Lester Barr and A.D. Baildam and has published in prestigious journals such as Annals of Tourism Research, British journal of surgery and Breast Cancer Research and Treatment.

In The Last Decade

Sue Down

25 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Down United Kingdom 11 214 204 151 68 51 25 404
Douglas Wood United States 13 139 0.6× 203 1.0× 168 1.1× 165 2.4× 29 0.6× 29 644
Rita Canas‐Marques Portugal 11 114 0.5× 85 0.4× 55 0.4× 75 1.1× 9 0.2× 27 366
Kelsey E. Larson United States 13 166 0.8× 157 0.8× 104 0.7× 221 3.3× 22 0.4× 52 507
David P. Gorczyca United States 15 424 2.0× 166 0.8× 198 1.3× 40 0.6× 24 0.5× 27 718
Alberto Rancati Argentina 13 422 2.0× 154 0.8× 37 0.2× 30 0.4× 20 0.4× 54 474
Sharon Chan China 10 156 0.7× 145 0.7× 86 0.6× 74 1.1× 10 0.2× 19 334
Emily S. Hu United States 7 591 2.8× 489 2.4× 190 1.3× 202 3.0× 46 0.9× 8 833
Mintsje de Boer Netherlands 11 439 2.1× 274 1.3× 188 1.2× 82 1.2× 7 0.1× 20 609
Krisztián Látó Germany 10 98 0.5× 102 0.5× 22 0.1× 121 1.8× 19 0.4× 26 333
Madoka Iwase Japan 11 45 0.2× 82 0.4× 44 0.3× 91 1.3× 14 0.3× 33 289

Countries citing papers authored by Sue Down

Since Specialization
Citations

This map shows the geographic impact of Sue Down's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Down with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Down more than expected).

Fields of papers citing papers by Sue Down

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Down. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Down. The network helps show where Sue Down may publish in the future.

Co-authorship network of co-authors of Sue Down

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Down. A scholar is included among the top collaborators of Sue Down based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Down. Sue Down is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Down, Sue, et al.. (2023). A single centre experience with Magtrace and sentimag system for sentinel lymph node localization. European Journal of Surgical Oncology. 49(5). e228–e228. 1 indexed citations
2.
Morgan, Jenna, Rajiv Dave, Yazan Masannat, et al.. (2022). Results of shared learning of a new magnetic seed localisation device – A UK iBRA-NET breast cancer localisation study. European Journal of Surgical Oncology. 48(12). 2408–2413. 5 indexed citations
3.
Dave, Rajiv, Chris Holcombe, Shelley Potter, et al.. (2021). A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study. PubMed. 25(1). 26–33. 5 indexed citations
4.
Dave, Rajiv, Emma Barrett, Nicola Barnes, et al.. (2021). 07. The iBRANET localisation study; A National cohort study of wire-guided and Magseed-guided localisation for impalpable breast lesions. European Journal of Surgical Oncology. 47(5). e287–e288. 1 indexed citations
5.
Leinster, Sam, et al.. (2021). Blended Learning in Healthcare Education. Medical Research Archives. 9(8). 5 indexed citations
6.
Potter, Shelley, Anthony Maxwell, Amtul Sami, et al.. (2020). Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire. Breast Cancer Research and Treatment. 185(1). 13–20. 12 indexed citations
7.
Down, Sue, et al.. (2019). Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study. European Journal of Surgical Oncology. 45(11). 2016–2021. 67 indexed citations
8.
Down, Sue, et al.. (2019). P037. Magseed localisation of non palpable breast cancer. Is the future magnetic?. European Journal of Surgical Oncology. 45(5). 895–896. 1 indexed citations
9.
Photi, Evangelos, et al.. (2019). P152. A DGH’s experience using Magseed as a localisation tool for impalpable breast lesions. European Journal of Surgical Oncology. 45(5). 923–924. 1 indexed citations
10.
Down, Sue, et al.. (2019). Is the future magnetic? Magseed localisation of non palpable breast cancer – a multicentre comparative cohort study. The Breast. 44. S112–S112. 1 indexed citations
11.
Down, Sue, Olivia Lucas, John R. Benson, & Gordon Wishart. (2014). Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer. Oncology Letters. 8(6). 2757–2761. 15 indexed citations
12.
Down, Sue, et al.. (2014). Techniques to reduce seroma formation after mastectomy and axillary clearance: Current trends amongst UK breast surgeons. European Journal of Surgical Oncology. 40(5). 642–642. 2 indexed citations
13.
Down, Sue, Jerome Pereira, Sam Leinster, & Andrew K. Simpson. (2013). Training the oncoplastic breast surgeon-current and future perspectives.. PubMed. 2(3). 126–7. 12 indexed citations
14.
Down, Sue, et al.. (2013). Oncological Advantages of Oncoplastic Breast-Conserving Surgery in Treatment of Early Breast Cancer. The Breast Journal. 19(1). 56–63. 74 indexed citations
16.
Mannu, Gurdeep, et al.. (2012). Sentinel lymph node biopsy before mastectomy and immediate breast reconstruction may predict post-mastectomy radiotherapy and improves the choice of reconstruction.. European Journal of Surgical Oncology. 38(5). 420–420. 1 indexed citations
17.
Badurdeen, Shiraz, et al.. (2010). Nintendo Wii video-gaming ability predicts laparoscopic skill. Surgical Endoscopy. 24(8). 1824–1828. 86 indexed citations
18.
Down, Sue, et al.. (2010). Invasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?. International Journal of Surgery. 8(5). 346–352. 14 indexed citations
19.
Down, Sue, et al.. (2010). Low ninety-day re-admission rates after emergency and elective laparoscopic cholecystectomy in a district general hospital. Annals of The Royal College of Surgeons of England. 92(4). 307–310. 11 indexed citations
20.
Down, Sue, Lester Barr, A.D. Baildam, & N.J. Bundred. (2003). Management of accessory breast tissue in the axilla. British journal of surgery. 90(10). 1213–1214. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026